Epigenetics of hypertension as a risk factor for the development of coronary artery disease in type 2 diabetes mellitus

被引:3
|
作者
Karabaeva, Raushan Zh [1 ]
Vochshenkova, Tamara A. [1 ]
Mussin, Nadiar M. [2 ]
Albayev, Rustam K. [1 ]
Kaliyev, Asset A. [2 ]
Tamadon, Amin [3 ,4 ]
机构
[1] Presidents Affairs Adm Republ Kazakhstan, Med Ctr Hosp, Gerontol Ctr, Astana, Kazakhstan
[2] West Kazakhstan Marat Ospanov Med Univ, Gen Surg, Aktobe, Kazakhstan
[3] West Kazakhstan Marat Ospanov Med Univ, Dept Nat Sci, Aktobe, Kazakhstan
[4] PerciaVista R&D Co, Dept Res & Dev, Shiraz, Iran
来源
FRONTIERS IN ENDOCRINOLOGY | 2024年 / 15卷
关键词
coronary artery disease; hypertension; type 2 diabetes mellitus; epigenetics; genetic variation; DNA methylation; histone; modification; DNA METHYLATION; BLOOD-PRESSURE; CARDIAC-HYPERTROPHY; LIFE-STYLE; GENE; MODULATION; EXPRESSION; SALT; PREECLAMPSIA; DEFICIENCY;
D O I
10.3389/fendo.2024.1365738
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension, a multifaceted cardiovascular disorder influenced by genetic, epigenetic, and environmental factors, poses a significant risk for the development of coronary artery disease (CAD) in individuals with type 2 diabetes mellitus (T2DM). Epigenetic alterations, particularly in histone modifications, DNA methylation, and microRNAs, play a pivotal role in unraveling the complex molecular underpinnings of blood pressure regulation. This review emphasizes the crucial interplay between epigenetic attributes and hypertension, shedding light on the prominence of DNA methylation, both globally and at the gene-specific level, in essential hypertension. Additionally, histone modifications, including acetylation and methylation, emerge as essential epigenetic markers linked to hypertension. Furthermore, microRNAs exert regulatory influence on blood pressure homeostasis, targeting key genes within the aldosterone and renin-angiotensin pathways. Understanding the intricate crosstalk between genetics and epigenetics in hypertension is particularly pertinent in the context of its interaction with T2DM, where hypertension serves as a notable risk factor for the development of CAD. These findings not only contribute to the comprehensive elucidation of essential hypertension but also offer promising avenues for innovative strategies in the prevention and treatment of cardiovascular complications, especially in the context of T2DM.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] An atherogenic midband lipoprotein: a risk factor for coronary artery disease in diabetes mellitus with hyperlipidemia
    Kawano, M
    Shinomiya, M
    Kanzaki, T
    Morisaki, N
    Shirai, K
    Saito, Y
    Yoshida, S
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 41 (01) : 45 - 48
  • [22] Epigenetics and Type 2 Diabetes Risk
    Dhawan, Sangeeta
    Natarajan, Rama
    CURRENT DIABETES REPORTS, 2019, 19 (08)
  • [23] Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus
    Oe, Momoko
    Fujihara, Kazuya
    Yamada, Mayuko Harada
    Osawa, Taeko
    Kitazawa, Masaru
    Matsubayashi, Yasuhiro
    Sato, Takaaki
    Yaguchi, Yuta
    Iwanaga, Midori
    Yamada, Takaho
    Sone, Hirohito
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (10) : 1464 - 1471
  • [24] Additional Effect of Diabetes Mellitus Type 2 on the Risk of Coronary Artery Disease: Role of Serum Adiponectin
    Mohammadzadeh, Ghorban
    Ghaffari, Mohammad-Ali
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (01)
  • [25] Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus
    Farhan, Serdar
    Hochtl, Thomas
    Kautzky-Willer, Alexandra
    Wojta, Johann
    Huber, Kurt
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (1-2) : 30 - 38
  • [26] The effect of type 2 diabetes mellitus on multiple obstructive coronary artery disease
    Jiang, Luying
    Liu, Jingbo
    Yang, Zhenjia
    Zhang, Chunran
    Wang, Jianyu
    Ke, Wenkai
    Zuo, Houjuan
    Wang, Li
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2023, 40 (03): : 235 - 243
  • [27] Screening for asymptomatic coronary artery disease in patients with type 2 diabetes mellitus
    Tavares, Carlos Augusto F.
    Wajchjenberg, Bernardo Leo
    Rochitte, Carlos
    Lerario, Antonio Carlos
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2016, 60 (02): : 143 - 151
  • [28] Serum protein signature of coronary artery disease in type 2 diabetes mellitus
    Adela, Ramu
    Reddy, Podduturu Naveen Chander
    Ghosh, Tarini Shankar
    Aggarwal, Suruchi
    Yadav, Amit Kumar
    Das, Bhabatosh
    Banerjee, Sanjay K.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
  • [29] Screening for coronary artery disease in asymptomatic patients with type 2 diabetes mellitus
    Shen Wei-Feng
    CHINESE MEDICAL JOURNAL, 2007, 120 (21) : 1859 - 1861
  • [30] Screening for coronary artery disease in asymptomatic patients with type 2 diabetes mellitus
    SHEN Wei-feng Department of Cardiology
    中华医学杂志(英文版), 2007, (21) : 1859 - 1861